In this study, using a comprehensive approach based on tumor testing for the assessment of MSI status, clinical evaluation of patients and their relatives, and genetic analysis, we identified a spectrum of variants in MMR genes and other cancer genes. This evidence concerns the gene MRC1 and neoplasm.